Infiltrating Bladder Urothelial Carcinoma

Search with Google Search with Bing
Information
Disease name
Infiltrating Bladder Urothelial Carcinoma
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT03549715 Active, not recruiting Phase 1/Phase 2 NEoadjuvant Dose-dense MVAC In cOmbination With Durvalumab and Tremelimumab in Muscle-invasive Urothelial Carcinoma December 6, 2018 September 2025
NCT01495676 Active, not recruiting N/A A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer July 6, 2011 September 2025
NCT03609216 Recruiting Phase 2 Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations August 1, 2018 February 2029
NCT02767921 Terminated Phase 1 sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer August 2, 2016 November 15, 2021
NCT01616875 Unknown status Phase 2 Bristol Bladder Trial May 2012 January 2023
NCT02944357 Withdrawn N/A Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery November 2016 September 5, 2017
NCT03238664 Withdrawn N/A Robot-Assisted Laparoscopic High-Intensity Focused Ultrasound and Radical Cystectomy for Thermal Ablation of Muscle Invasive Cells in Patients With Bladder Tumors January 22, 2018 January 22, 2020
NCT03419130 Withdrawn Phase 2 Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer July 18, 2018 December 31, 2022
NCT02688348 Withdrawn N/A Quality of Life After Bladder-Preservation Chemotherapy and Radiation Therapy in Patients With Muscle-Invasive Bladder Cancer April 22, 2015 February 28, 2019